Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Bayer : Brazil agency says Bayer-Monsanto tie-up can hurt competition, urges conditions

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/04/2017 | 08:41pm CET
FILE PHOTO: Monsanto logo is displayed on a screen where the stock is traded on the floor of the NYSE

SAO PAULO (Reuters) - A unit of Brazil's competition regulator Cade has said Bayer AG's (>> Bayer) proposed takeover of Monsanto Co. (>> Monsanto) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows.

SAO PAULO (Reuters) - A unit of Brazil's competition regulator Cade has said Bayer AG's (>> Bayer) proposed takeover of Monsanto Co. (>> Monsanto) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows.

The Bayer-Monsanto transaction, announced in September 2016, would create the world's largest integrated pesticides and seeds company.

The Cade unit said that anticipated merger-related efficiencies were insufficient to mitigate its competition concerns, according to the document dated Oct. 3.

It recommended what it termed as "structural solutions" as a condition for final approval the deal, which will be in the hands of Cade's seven-member tribunal.

Cade has 330 days to make a final decision since it began its review of the deal on April 24, a spokesman for the agency said. However, he added it may announce a ruling as early as Dec. 20.

The Cade unit said solutions included creating or strengthening another player to compete in the markets for soy and cotton seeds and in the sphere of biotech development.

But the unit has not engaged in an in-depth discussion with Bayer and Monsanto related to its suggested "remedies," the document said.

In an emailed statement to Reuters, Bayer said the unit's opinion is non-binding and does not mean the transaction will be blocked.

Hugh Grant, Monsanto's chief executive officer, said concerns expressed by Brazil's regulator are a normal step in the review process.

Brazil is Monsanto's biggest market outside of the United States.

In its second-quarter results, Bayer said sales of its crop science division tumbled more than 15 percent primarily because of its business in Brazil, an indication of the country's weight as a market for seed technology, insecticides and herbicides.

Deal opponents have asked Cade to block it or force divestments including Monsanto's Intacta RR2 IPRO soy seed technology and Bayer's glufosinate ammonium herbicides.

Last week, Monsanto's chief executive officer for South America, Rodrigo Santos, told Reuters the company was set on keeping rights to Intacta.

Cotton farmers against the transaction assert the merged company would control 14 out of 15 genetically modified cotton seed technologies available in Brazil.

If Cade orders asset disposals from the companies, authorities must see to it that the buyer is a relevant player in the biotech, seed production and crop defence segments, said attorney Rachel Mendonça, a partner at Mendonça e Nogueira Advogados.

Her law firm is representing three industry groups opposing the deal.

(Reporting by Ana Mano; editing by Alexander Smith and W Simon)

By Ana Mano

Stocks treated in this article : Monsanto, Bayer
Stocks mentioned in the article
ChangeLast1st jan.
MONSANTO 1.10% 121.74 Delayed Quote.3.12%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
02/23BAYER : Patent Issued for Methods and Compositions for Reducing Anguina Nematode..
AQ
02/23BAYER : Patent Issued for Tubing Connectors (USPTO 9889288)
AQ
02/22Seed firms scramble to stop a 'cancer' in Canada's cash crop
RE
02/21BAYER : announces publication of larotrectinib data in The New England Journal o..
PU
02/21BAYER AKTIENGESELLSCHAFT : Preliminary announcement of the publication of financ..
EQ
02/19BASF to face millions in extra costs in UK each year from Brexit - Handelsbla..
RE
02/19Rare Haematology Market Trend to 2025 Profiling PRA Health Sciences, Bayer He..
AQ
02/16BAYER : fördert freiwilliges Mitarbeiter-Engagement seit zehn Jahren
PU
02/15BAYER : Researchers Submit Patent Application, "Antibody and Protein Formulation..
AQ
02/15BAYER : Recent Findings in Pesticides Described by Researchers from Bayer (Refin..
AQ
More news
News from SeekingAlpha
08:01a3 THINGS IN BIOTECH YOU SHOULD LEARN : February 24, 2018 
02/22Regeneron's Eylea sees uptick in side effects, cause unknown 
02/20Tracking John Paulson's Paulson & Company Portfolio - Q4 2017 Update 
02/16Tracking David Einhorn's Portfolio - Q4 2017 Update 
02/15Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2017 Update 
Financials (€)
Sales 2017 35 346 M
EBIT 2017 7 351 M
Net income 2017 6 740 M
Debt 2017 8 806 M
Yield 2017 2,64%
P/E ratio 2017 13,70
P/E ratio 2018 18,14
EV / Sales 2017 2,55x
EV / Sales 2018 2,51x
Capitalization 81 396 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 120 €
Spread / Average Target 22%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-5.85%100 069
JOHNSON & JOHNSON-7.02%349 006
NOVARTIS-2.94%222 939
PFIZER-1.33%213 155
ROCHE HOLDING LTD.-9.41%207 036
MERCK AND COMPANY-3.02%148 618